Coming from a medical background, diagnostic tests with bacterial/viral DNA & RNA is already available but costly. Their costs in running a test can be improved with different innovations in the future.
This however cannot replace bacteria culture onto plates because culture plates is essential to test if an antibiotic is effective in order to kill off the bacteria that was cultured.
While genetic testing can tell us quickly which bug it is that's making us sick, it doesn't tell us what is the best way to kill the bug. With the growing threat of antibiotics resistance / super bugs, identifying the correct antibiotic to use in a timely manner is critical in healthcare for a patient and slowing down the rate of antibiotic resistance in the community for the future.
The potential of LBT will be much greater in comparison with the aforementioned diagnostic tests.
Coming from a medical background, diagnostic tests with...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LBT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.8¢ |
Change
0.002(12.5%) |
Mkt cap ! $31.63M | |||
| Open | High | Low | Value | Volume |
| 1.7¢ | 1.8¢ | 1.7¢ | $3.899K | 228.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 361155 | 1.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.8¢ | 1523195 | 7 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| LBT (ASX) Chart |